New DxN VERIS Molecular Diagnostics System at ESCV Edinburgh
Unique System Proven to Improve Laboratory Workflow and Productivity for Infectious Disease
Beckman Coulter Diagnostics is showcasing its DxN VERIS Molecular Diagnostics System* at the European Society for Clinical Virology (ESCV) meeting in Edinburgh, Scotland, 9-12 September 2015 on booth G5 where delegates can learn more about this new instrument that is set to revolutionise laboratory workflow.
Recent evaluations undertaken in the UK and Spain have shown that DxN VERIS is simple to use (routine operator training taking approximately 20 minutes from start to full system operation), dramatically reduces hands-on time (as only one instrument is required that incorporates extraction, amplification and detection), provides true single sample random access allowing multiple assays and samples to be run at the same time, and enables laboratories to go from sample to auto-verified result in just 70 minutes.
Assays are supplied in a unique, single cartridge system so, unlike traditional batch-plate systems, there are no empty wells, reducing wastage and consumable costs. With the DxN VERIS Molecular Diagnostics System, all necessary consumables and reagents are on-board, so there is no lengthy set-up and tests can be up and running in less than 10 minutes.
The system is fully CE-marked, with assays for Human Immunodeficiency Virus (HIV-1), Hepatitis C Virus (HCV), Hepatitis B Virus (HBV) and Human Cytomegalovirus (CMV). Further menu expansion will follow with many other assays currently in development.
Come and join us on booth G5 for a system demonstration, or if you are unable to attend the event, for more information about the evaluation studies and copies of the new posters presented at ESCV and other meetings, please visit: www.beckmancoulter.com/moleculardiagnostics or email email@example.com
Tags: Cytomegalovirus, Hepatitis C, HIV, Hepatitis B
Date Published: September 2, 2015
Source article link: Beckman Coulter Inc. » company contact details
Automated Hepatitis Viral Load Testing Offered at LabCorp
Vela Achieves CE-IVD Marking for HCV Genotyping NGS Assay
More CMV Positives Found with DxN VERIS vs COBAS®
Excellent Results from Multi-Centre Evaluation of DxN VERIS HIV-1 Assay